ERA/EDTA Congress News. Day 2. |
ERA/EDTA Congress News. Day 1. |
Baxter presents VIVIA HD machine data at ERA/EDTA |
Bloomberg: Baxter International Inc. (NYSE:BAX) today announced the presentation of clinical data supporting the safety and efficacy of the VIVIA haemodialysis (HD) system. Results from two studies conducted in a clinical setting showed acceptable clearance of uremic toxins and an overall safety profile similar to that associated with conventional HD devices. The VIVIA system, designed to deliver High Dose HD in the home, completed the CE marking process (market approval) in Europe, December 2013. The VIVIA haemodialysis system, which completed the CE marking process in Europe in December 2013, was designed to deliver High Dose HD therapy in the home.
|
Samsung plans to open source digital health gadgets. |
MDDI: This week Samsung put out a call to innovative startups to join it in creating the next-generation of wearable platforms for digital health. The company has announced a $50 million investment fund it is calling the Samsung Digital Health Challenge and wants to develop advanced data collection sensors and algorithms that will create actionable analysis of health tracking data. And it wants to use open hardware and software to do it. Essentially Samsung is creating a digital health playground and it wants startups, entrepreneurs, and research organizations to get into the sandbox.
|